{"transactions":[{"id":2944546,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO"}}],"security":"Common Stock","published_at":"2020-12-15T06:31:03.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":6603,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":7477,"source":{"system":"sec-edgar","filing":"0001493152-20-023601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000149315220023601/ownership.xml","form_type":"4"}},{"id":3590689,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-03-18T19:58:13.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on March 14, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date."}],"balance_after":350000,"derivative":{"exercise_price":3.52,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-19-020135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000120919119020135/doc4.xml","form_type":"4"}},{"id":3857892,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Research & Development"}}],"security":"Common stock purchase warrants","published_at":"2018-07-31T21:38:54.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":874,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":874},"source":{"system":"sec-edgar","filing":"0001493152-18-010762","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000149315218010762/ownership.xml","form_type":"4"}},{"id":3857891,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Research & Development"}}],"security":"Common stock, no par value","published_at":"2018-07-31T21:38:54.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":874,"source":{"system":"sec-edgar","filing":"0001493152-18-010762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000149315218010762/ownership.xml","form_type":"4"}},{"id":3908563,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Research & Development"}}],"security":"Option to Purchase Common Stock","published_at":"2018-06-04T20:51:15.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest as to one-third of the shares on each of the completion of the clinical utility study for OncoCyte's DetermaVu product candidate, the filing of the Medicare dossier for the Medicare local coverage determination, and obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate."}],"balance_after":150000,"derivative":{"exercise_price":2.35,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-035400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000120919118035400/doc4.xml","form_type":"4"}},{"id":4431737,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":144647,"kind":"person","name":"HESTERBERG LYNDAL K.","position":1,"cik":"0001689836","reported_name":"HESTERBERG LYNDAL K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Research & Development"}}],"security":"Option to Purchase Common Stock","published_at":"2017-02-22T21:35:42.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on February 16, 2018, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant."}],"balance_after":14400,"derivative":{"exercise_price":4.7,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001209191-17-013565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689836/000120919117013565/doc4.xml","form_type":"4"}}]}